Analyst consensus rating
Syndax Pharmaceuticals Analyst Rating: Strong Buy
SNDX is rated Strong Buy by 11 analysts with a $37.55 target. As of 2026-08-26.
Direct answer
Syndax Pharmaceuticals's consensus rating is Strong Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $37.55.
Forecast evidence checked August 26, 2026.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.92
- Average price target
- $37.55
- High price target
- $57.00
- Low price target
- $26.00
- Low target gap
- +30.5%
- Target upside
- +88.5%
- High target gap
- +186.1%
- Target range width
- 155.6%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Syndax Pharmaceuticals?
Syndax Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $37.55.
How far are Syndax Pharmaceuticals's low and high targets from the recorded price?
The low target implies +30.5%, while the high target implies +186.1%.
How many analysts are included in Syndax Pharmaceuticals's consensus?
The verified consensus includes 11 analysts.
How is Syndax Pharmaceuticals's target upside or downside calculated?
The average target of $37.55 is divided by the recorded price of $19.92, then one is subtracted to produce +88.5%. This does not guarantee a future return.
When was Syndax Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.